Lv3
210 积分 2022-06-21 加入
Sintilimab (PD-1 inhibitor) plus lenvatinib as conversion therapy followed by sequential surgery (SILENSES) for advanced unresectable hepatocellular carcinoma: a phase II, expansion trial
5天前
已完结
RUPE-phospho: Rapid Ultrasound-Assisted Peptide-Identification-Enhanced Phosphoproteomics Workflow for Microscale Samples
9天前
已完结
RUPE-phospho: Rapid Ultrasound-Assisted Peptide-Identification-Enhanced Phosphoproteomics Workflow for Microscale Samples
9天前
已完结
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
13天前
已完结
Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers
24天前
已完结
Precision surgery for hepatocellular carcinoma
25天前
已完结
Ex-vivo liver resection and autotransplantation for liver malignancy: a large volume retrospective clinical study
25天前
已完结
Proteogenomic characterization reveals that lipid droplet formation promotes esophageal squamous cell cancer progression
27天前
已完结
Efficient discovery of robust prognostic biomarkers and signatures in solid tumors
27天前
已完结
Proteomics-based machine learning model for predicting secondary infection in HBV-related liver failure
1个月前
已完结
皖公网安备34019202002308
